Publications

  1. Baheti S, Singh P, Zhang Y, Evans J, Jensen MD, Somers VK, Kocher JA, Sun Z, Chakkera HA. Adipose tissue DNA methylome changes in development of new-onset diabetes after kidney transplantation. Epigenomics. 2017 Oct 02 [Epub ahead of print]
    View PubMed
  2. Chakkera HA, Sharif A, Kaplan B. Negative Cardiovascular Consequences of Small Molecule Immunosuppressants. Clin Pharmacol Ther. 2017 Aug; 102: (2)269-276.
    View PubMed
  3. Alhamad T, Malone AF, Lentine KL, Brennan DC, Wellen J, Chang SH, Chakkera HA. Selected Mildly Obese Donors Can Be Used Safely in Simultaneous Pancreas and Kidney Transplantation. Transplantation. 2017 Jun; 101 (6):1159-1166
    View PubMed
  4. Patel SI, Chakkera HA, Wennberg PW, Liedl DA, Alrabadi F, Cha SS, Hooley DD, Amer H, Wadei HM, Shamoun FE. Peripheral arterial disease preoperatively may predict graft failure and mortality in kidney transplant recipients. Vasc Med. 2017 Jun; 22 (3):225-230 Epub 2017 Mar 17
    View PubMed
  5. Williams RC, Opelz G, Weil EJ, McGarvey CJ, Chakkera HA. The Risk of Transplant Failure With HLA Mismatch in First Adult Kidney Allografts 2: Living Donors, Summary, Guide. Transplant Direct. 2017 May; 3 (5):e152 Epub 2017 Apr 07
    View PubMed
  6. Denic A, Lieske JC, Chakkera HA, Poggio ED, Alexander MP, Singh P, Kremers WK, Lerman LO, Rule AD. The Substantial Loss of Nephrons in Healthy Human Kidneys with Aging. J Am Soc Nephrol. 2017 Jan; 28: (1)313-320.
    View PubMed
  7. Chakkera HA, Kudva Y, Kaplan B. Calcineurin Inhibitors: Pharmacologic Mechanisms Impacting Both Insulin Resistance and Insulin Secretion Leading to Glucose Dysregulation and Diabetes Mellitus. Clin Pharmacol Ther. 2017 Jan; 101: (1)114-120.
    View PubMed
  8. Kahn A, Reynolds JA, Chakkera HA, Aqel BA, Byrne TJ, Douglas DD, Moss AA, Vargas HE, Carey EJ. Prospective Analysis of Metabolic Parameters in the Detection of Diabetes and Metabolic Syndrome in Liver Transplant Recipients. Metab Syndr Relat Disord. 2016 Aug; 14: (6)305-10.
    View PubMed
  9. Chakkera HA, Schold JD, Kaplan B. P Value: Significance Is Not All Black and White (Commentary). Transplantation. 2016 Aug; 100: (8)1607-9.
    View PubMed
  10. Denic A, Alexander MP, Kaushik V, Lerman LO, Lieske JC, Stegall MD, Larson JJ, Kremers WK, Vrtiska TJ, Chakkera HA, Poggio ED, Rule AD. Detection and Clinical Patterns of Nephron Hypertrophy and Nephrosclerosis Among Apparently Healthy Adults. Am J Kidney Dis. 2016 Jul; 68 (1):58-67 Epub 2016 Feb 06
    View PubMed
  11. Qaqish I, Schlam IM, Chakkera HA, Fonseca R, Adamski J. Carfilzomib: A cause of drug associated thrombotic microangiopathy. Transfus Apher Sci. 2016 Jun; 54: (3)401-4.
    View PubMed
  12. Williams RC, Opelz G, McGarvey CJ, Weil EJ, Chakkera HA. The Risk of Transplant Failure With HLA Mismatch in First Adult Kidney Allografts From Deceased Donors. Transplantation. 2016 May; 100: (5)1094-102.
    View PubMed
  13. Batra RK, Heilman RL, Smith ML, Thomas LF, Khamash HA, Katariya NN, Hewitt WR, Singer AL, Mathur AK, Huskey J, Chakkera HA, Moss A, Reddy KS. Rapid Resolution of Donor-Derived Glomerular Fibrin Thrombi After Deceased Donor Kidney Transplantation. Am J Transplant. 2016 Mar; 16 (3):1015-20 Epub 2015 Dec 21
    View PubMed
  14. Werner KT, Mackey PA, Castro JC, Carey EJ, Chakkera HA, Cook CB. Hyperglycemia during the immediate period following liver transplantation. Future Sci OA. 2016 Mar; 2: (1)FSO97.
    View PubMed
  15. Chakkera HA, Kudva YC, Chang YH, Heilman RL, Singer AL, Mathur AK, Hewitt WR, Khamash HA, Huskey JL, Katariya NN, Moss AA, Behmen S, Reddy KS. Glucose homeostasis after simultaneous pancreas and kidney transplantation: a comparison of subjects with C-peptide-positive non-type 1 diabetes mellitus and type 1 diabetes mellitus. Clin Transplant. 2016 Jan; 30: (1)52-9.
    View PubMed
  16. Coletta DK, Campbell LE, Weil J, Kaplan B, Clarkson M, Finlayson J, Mandarino LJ, Chakkera HA. Changes in Pre- and Post-Exercise Gene Expression among Patients with Chronic Kidney Disease and Kidney Transplant Recipients. PLoS One. 2016; 11: (8)e0160327.
    View PubMed
  17. Kremers WK, Denic A, Lieske JC, Alexander MP, Kaushik V, Elsherbiny HE, Chakkera HA, Poggio ED, Rule AD. Distinguishing age-related from disease-related glomerulosclerosis on kidney biopsy: the Aging Kidney Anatomy study. Nephrol Dial Transplant. 2015 Dec; 30: (12)2034-9.
    View PubMed
  18. Disbrow MB, Qaqish I, Kransdorf M, Chakkera HA. Calcific uraemic arteriolopathy. BMJ Case Rep. 2015 Aug 27; 2015:
    View PubMed
  19. Heilman RL, Smith ML, Kurian SM, Huskey J, Batra RK, Chakkera HA, Katariya NN, Khamash H, Moss A, Salomon DR, Reddy KS. Transplanting Kidneys from Deceased Donors With Severe Acute Kidney Injury. Am J Transplant. 2015 Aug; 15: (8)2143-51.
    View PubMed
  20. Waterman AD, Morgievich M, Cohen DJ, Butt Z, Chakkera HA, Lindower C, Hays RE, Hiller JM, Lentine KL, Matas AJ, Poggio ED, Rees MA, Rodrigue JR, LaPointe Rudow D. Living Donor Kidney Transplantation: Improving Education Outside of Transplant Centers about Live Donor Transplantation-Recommendations from a Consensus Conference. Clin J Am Soc Nephrol. 2015 Jun 26.
    View PubMed
  21. Chakkera HA, Chang YH, Thomas LF, Avula RT, Amer H, Lerman LO, Denic A, Rule AD. Obesity Correlates With Glomerulomegaly But Is Not Associated With Kidney Dysfunction Early After Donation. Transplant Direct. 2015 Feb 01; 1: (1)1-6.
    View PubMed
  22. Boloori A, Saghafian S, Chakkera HA, Cook CB. Characterization of Remitting and Relapsing Hyperglycemia in Post-Renal-Transplant Recipients. PLoS One. 2015; 10: (11)e0142363.
    View PubMed
  23. Heilman RL, Nijim A, Desmarteau YM, Khamash H, Pando MJ, Smith ML, Chakkera HA, Huskey J, Valdez R, Reddy KS. De novo donor-specific human leukocyte antigen antibodies early after kidney transplantation. Transplantation. 2014 Dec 27; 98(12):1310-5.
    View PubMed
  24. Wang X, Vrtiska TJ, Avula RT, Walters LR, Chakkera HA, Kremers WK, Lerman LO, Rule AD. Age, kidney function, and risk factors associate differently with cortical and medullary volumes of the kidney. Kidney Int. 2014 Mar; 85: (3)677-85.
    View PubMed
  25. Heilman RL, Khamash HA, Huskey JL, Chakkera HA, Batra RK, Katariya NN, Singer AL, Mathur AK, Moss AA, Reddy KS. Kidney Transplant Program at the Mayo Clinic in Arizona. Clin Transpl. 2014:61-8.
    View PubMed
  26. Deng Y, Pandit A, Heilman RL, Chakkera HA, Mazur MJ, Mookadam F. Left ventricular torsion changes post kidney transplantation. J Cardiovasc Ultrasound. 2013 Dec; 21: (4)171-6.
    View PubMed
  27. Chakkera HA, Chang YH, Ayub A, Gonwa TA, Weil EJ, Knowler WC. Validation of a pretransplant risk score for new-onset diabetes after kidney transplantation. Diabetes Care. 2013 Oct; 36(10):2881-6. Epub 2013 Sep 05.
    View PubMed
  28. Heilman RL, Khamash HA, Smith ML, Chakkera HA, Moss AA, Reddy KS. Delayed allograft inflammation following alemtuzumab induction for kidney transplantation. Clin Transplant. 2013 Sep-Oct; 27: (5)772-80.
    View PubMed
  29. Chakkera HA, Weil EJ, Pham PT, Pomeroy J, Knowler WC. Can new-onset diabetes after kidney transplant be prevented? Diabetes Care. 2013 May; 36: (5)1406-12.
    View PubMed
  30. Chakkera HA, Mandarino LJ. Calcineurin inhibition and new-onset diabetes mellitus after transplantation. Transplantation. 2013 Mar 15; 95: (5)647-52.
    View PubMed
  31. Chakkera HA, Chang YH, Bodner JK, Behmen S, Heilman RL, Reddy KS, Mulligan DC, Moss AA, Khamash H, Katariya N, Hewitt WR, Pitta TL, Frassetto LA. Genetic differences in Native Americans and tacrolimus dosing after kidney transplantation. Transplant Proc. 2013 Jan-Feb; 45(1):137-41.
    View PubMed
  32. Yadav AD, Chang YH, Aqel BA, Byrne TJ, Chakkera HA, Douglas DD, Mulligan DC, Rakela J, Vargas HE, Carey EJ. New Onset Diabetes Mellitus in Living Donor versus Deceased Donor Liver Transplant Recipients: Analysis of the UNOSOPTN Database. J Transplant. 2013; 2013:269096.
    View PubMed
  33. Chakkera HA, Knowler WC. Response to comment on: Chakkera et al. Pretransplant risk score for new-onset diabetes after kidney transplantation. Diabetes Care 2011;34:2141-2145. Diabetes Care. 2012; 35(3):e27.
  34. Carey EJ, Aqel BA, Byrne TJ, Douglas DD, Rakela J, Vargas HE, Moss AA, Mulligan DC, Reddy KS, Chakkera HA. Pretransplant fasting glucose predicts new-onset diabetes after liver transplantation. J Transplant. 2012; 2012:614781.
    View PubMed
  35. Pham PT, Edling KL, Chakkera HA, Pham PC, Pham PM. Screening strategies and predictive diagnostic tools for the development of new-onset diabetes mellitus after transplantation: an overview. Diabetes Metab Syndr Obes. 2012; 5:379-87. Epub 2012 Oct 26.
    View PubMed
  36. Grover A, Frassetto LA, Benet LZ, Chakkera HA. Pharmacokinetic differences corroborate observed low tacrolimus dosage in Native American renal transplant patients. Drug Metab Dispos. 2011 Nov; 39: (11)2017-9.
    View PubMed
  37. Mazur MJ, Lowney AC, Prigoff J, Heilman RL, Chakkera H, Moss A, Mulligan D, Reddy K, Hamawi K. Resolution of long-standing necrobiosis lipoidica diabeticorum (NLD) lesion after restoration of euglycemia following successful pancreas after kidney (PAK) transplantation: a case report. Transplant Proc. 2011 Nov; 43: (9)3296-8.
    View PubMed
  38. Heilman RL, Younan K, Wadei HM, Mai ML, Reddy KS, Chakkera HA, Gonwa TA. Results of a prospective randomized trial of sirolimus conversion in kidney transplant recipients on early corticosteroid withdrawal. Transplantation. 2011 Oct 15; 92: (7)767-73.
    View PubMed
  39. Chakkera HA, Weil EJ, Swanson CM, Dueck AC, Heilman RL, Reddy KS, Hamawi K, Khamash H, Moss AA, Mulligan DC, Katariya N, Knowler WC. Pretransplant risk score for new-onset diabetes after kidney transplantation. Diabetes Care. 2011 Oct; 34: (10)2141-5.
    View PubMed
  40. Chakkera HA, Hanson RL, Kobes S, Millis MP, Nelson RG, Knowler WC, Distefano JK. Association of variants in the carnosine peptidase 1 gene (CNDP1) with diabetic nephropathy in American Indians. Mol Genet Metab. 2011 Jun; 103: (2)185-90.
    View PubMed
  41. Heilman RL, Nijim S, Chakkera HA, Devarapalli Y, Moss AA, Mulligan DC, Mazur MJ, Hamawi K, Williams JW, Reddy KS. Impact of acute rejection on kidney allograft outcomes in recipients on rapid steroid withdrawal. J Transplant. 2011; 2011:583981. Epub 2011 May 15.
    View PubMed
  42. Chakkera HA, Bodner JK, Heilman RL, Mulligan DC, Moss AA, Mekeel KL, Mazur MJ, Hamawi K, Ray RM, Beck GL, Reddy KS. Outcomes after simultaneous pancreas and kidney transplantation and the discriminative ability of the C-peptide measurement pretransplant among type 1 and type 2 diabetes mellitus. Transplant Proc. 2010 Sep; 42: (7)2650-2.
    View PubMed
  43. Chakkera HA, Knowler WC, Devarapalli Y, Weil EJ, Heilman RL, Dueck A, Mulligan DC, Reddy KS, Moss AA, Mekeel KL, Mazur MJ, Hamawi K, Castro JC, Cook CB. Relationship between inpatient hyperglycemia and insulin treatment after kidney transplantation and future new onset diabetes mellitus. Clin J Am Soc Nephrol. 2010 Sep; 5: (9)1669-75.
    View PubMed
  44. Reddy KS, Devarapalli Y, Mazur M, Hamawi K, Chakkera H, Moss A, Mekeel K, Post D, Heilman R, Mulligan D. Alemtuzumab with rapid steroid taper in simultaneous kidney and pancreas transplantation: comparison to induction with antithymocyte globulin. Transplant Proc. 2010 Jul-Aug; 42: (6)2006-8.
    View PubMed
  45. Heilman RL, Devarapalli Y, Chakkera HA, Mekeel KL, Moss AA, Mulligan DC, Mazur MJ, Hamawi K, Williams JW, Reddy KS. Impact of subclinical inflammation on the development of interstitial fibrosis and tubular atrophy in kidney transplant recipients. Am J Transplant. 2010 Mar; 10(3):563-70. Epub 2010 Feb 01.
    View PubMed
  46. Mekeel KL, Daley SM, Andrews PE, Moss AA, Heilman RL, Mazur MJ, Chakkera HA, Hamawi K, Mulligan DC, Sudhakar Reddy K. Successful transplantation of a split crossed fused ectopic kidney into a patient with end-stage renal disease. J Transplant. 2010; 2010:383972. Epub 2010 Mar 25.
    View PubMed
  47. Chakkera HA, Hanson RL, Raza SM, DiStefano JK, Millis MP, Heilman RL, Mulligan DC, Reddy KS, Mazur MJ, Hamawi K, Moss AA, Mekeel KL, Cerhan JR. Pilot study: association of traditional and genetic risk factors and new-onset diabetes mellitus following kidney transplantation. Transplant Proc. 2009 Dec; 41: (10)4172-7.
    View PubMed
  48. Mekeel KL, Moss AA, Mulligan DC, Chakkera HA, Hamawi K, Mazur MJ, Heilman RL, Reddy KS. Deceased donor kidney transplantation from donors with acute renal failure due to rhabdomyolysis. Am J Transplant. 2009 Jul; 9(7):1666-70. Epub 2009 May 20.
    View PubMed
  49. Chakkera HA, Weil EJ, Castro J, Heilman RL, Reddy KS, Mazur MJ, Hamawi K, Mulligan DC, Moss AA, Mekeel KL, Cosio FG, Cook CB. Hyperglycemia during the immediate period after kidney transplantation. Clin J Am Soc Nephrol. 2009 Apr; 4: (4)853-9.
    View PubMed
  50. Chakkera HA, Chertow GM, O'Hare AM, Amend WJ Jr, Gonwa TA. Regional variation in kidney transplant outcomes: trends over time. Clin J Am Soc Nephrol. 2009 Jan; 4(1):152-9. Epub 2008 Oct 15.
    View PubMed
  51. Hastings D, Patel B, Torloni AS, Mookadam F, Betcher J, Moss A, Heilman R, Mazur M, Hamawi K, Mulligan D, Reddy K, Mekeel K, Chakkera H. Plasmapheresis therapy for rare but potentially fatal reaction to rituximab. J Clin Apher. 2009; 24(1):28-31.
    View PubMed
  52. Heilman RL, Chakkera H, Mazur M, Petrides S, Moss A, Mekeel K, Mulligan D, Reddy KS. Outcomes of simultaneous kidney-pancreas transplantation with positive cross-match. Transplant Proc. 2009 Jan-Feb; 41(1):303-6.
    View PubMed
  53. Hamawi K, Heilman RL, Mazur MJ, Chakkera HA, Mulligan DC, Moss AA, Mekeel KL, Reddy KS. Use of bortezomib for treatment of antibody medicated rejection in kidney transplant recipients--case report. Clin Transpl. 2009; 407-14.
    View PubMed
  54. Heilman RL, Chakkera HA, Reddy KS, Colby TV, Moss AA, Williams JW, Mazur MJ, Petrides S, Mulligan DC. Clinical factors associated with graft fibrosis in kidney-transplant recipients on steroid-avoidance immunosuppression. Clin Transplant. 2008 May-Jun; 22(3):309-15.
    View PubMed
  55. Mekeel KL, Mazur MJ, Reddy KS, Mulligan DC, Heilman RL, Chakkera HA, Andrews PE, Moss AA. Diffuse parenchymal urine leak after kidney transplantation following degloving injury during donor nephrectomy. Am J Transplant. 2007 Aug; 7: (8)2039-41.
    View PubMed
  56. Chakkera HA, O'Hare AM, Johansen KL, Hynes D, Stroupe K, Colin PM, Chertow GM. Influence of race on kidney transplant outcomes within and outside the Department of Veterans Affairs. J Am Soc Nephrol. 2005 Jan; 16: (1)269-77.
    View PubMed
  57. Su X, Zenios SA, Chakkera HA, Milford EL, Chertow GM. Diminishing significance of HLA matching in kidney transplantation. MPH American Journal of Transplant. 2004 Sept; 4(9):1501-8.
    View PubMed
  58. Kasiske BL, Chakkera H, Louis TA, Ma JZ. Immunosuppression withdrawal in renal transplantation. Transplant Proceeding. 2000 Nov; 32:1506-7.
  59. Kasiske BL, Chakkera HA, Louis TA, Ma JZ. A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol. 2000 Oct; 11: (10)1910-7.
    View PubMed
  60. Kasiske BL, Chakkera HA, Roel J. Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol. 2000 Sep; 11: (9)1735-43.
    View PubMed
  61. Kasiske BL, Chakkera H. Successful renal transplantation in American Indians. Transplantation. 1998 Jul 27; 66: (2)209-14.
    View PubMed